FTC conditionally approves Abbvie/Allergan with fireworks

The Federal Trade Commission has conditionally approved AbbVie’s $63 billion purchase of rival pharmaceutical company Allergan following a partisan vote and scathing commentary delivered by the commissioners.

Get unlimited access to all Global Competition Review content